Clinical trial
Comparative Study of the Efficacy and Safety of an Intra-articular Injection of ENKO 1 vs Durolane in Patients With Symptomatic Osteoarthritis of the Knee.
NCT03762408 is registered in ClinicalTrials.gov with OPKO Health, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Study of the Efficacy and Safety of an Intra-articular Injection of ENKO 1 vs Durolane in Patients With Symptomatic Osteoarthritis of the Knee.
- Lead sponsor
- OPKO Health, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 15, 2017
- Completion date
- May 29, 2020
- Enrollment
- 175 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.